Centre Hospitalier Regional Universitaire De Tours — Sponsor Intelligence | 29 EU Trials

Filter these 29 trials by condition, phase, country and more.

Open in Search →

29 Registered trials

17 Recruiting

4 Completed trials

1 Countries active

41 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 13 Phase II/III: 2 Phase II: 6 Phase I/II: 1 Phase III/IV: 2 Phase IV: 4 Phase I (FiH): 1

100%

4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Suicidal ideation 1 Chronic kidney disease 1 Malformation venous 1 Sickle cell anaemia 1 Lymphatic malformation 1 Interstitial lung disease 1 Post-traumatic stress disorder 1 Tracheobronchitis bacterial 1 COVID-19 1 Pneumocystis jirovecii pneumonia 1

Top IMPs

NITROGEN, OXYGEN 3 NITROUS OXIDE, OXYGEN 3 OXYGEN 2 SODIUM CHLORIDE 2 ACETYLSALICYLIC ACID 1 ALTEPLASE 1 AMIKACIN 1 B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), INFLUENZA VIRUS B/MICHIGAN/01/2021, INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED, INFLUENZA VIRUS A/CALIFORNIA/122/2022 SAN-022 (H3N2) STRAIN (SPLIT, INACTIVATED) 1 BASILIXIMAB 1 BEVACIZUMAB 1 BRETOVAMERAN 1 CARVEDILOL 1

All trials

29 total

PROSTABACT : Relevance of the treatment with antibiotics before endoscopic surgery of lower urinary symptoms related to prostate hypertrophy… Not authorised

2023-510191-31-00 Phase III 1 country
Propranolol for early secondary prevention of post-traumatic stress disorder in female victims of sexual violence: a single-center, randomiz… Pending

2023-504075-25-00 Phase II 1 country PROPRANOLOL
Efficacy of EMONO as an add-on therapy to conventional antidepressants for the treatment of depressive symptoms in nursing-home residents wi… Pending

2023-504691-18-00 Phase II 1 country NITROGEN, OXYGEN; NITROUS OXIDE, OXYGEN
A multicentre, double-blind, randomized controlled trial of inhaled amikacin versus placebo in critically ill patients with ventilator-assoc… Pending

2023-510075-63-00 Phase III 1 country AMIKACIN
Extending the time window for Tenecteplase by Effective RecanalizatioN of bAsilar artery occLusion in patients with POSTerior circulation st… Pending

2024-513444-28-00 Phase III 1 country ALTEPLASE; TENECTEPLASE
PRESENT - Prophylaxis of Recurrent Erysipelas in lower limbs: compreSsion thErapy vs aNTibiotics and compression therapy. A non-inferiority,… Pending

2024-513801-30-00 Phase III 1 country
ASPIRIN - Acetylsalicylic acid versus placebo in addition to a local non-steroidal anti-inflammatory drug in the treatment of thrombotic epi… Pending

2024-517595-38-00 Phase III 1 country ACETYLSALICYLIC ACID; DICLOFENAC DIETHYLAMINE
Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care: the PEDIADEX randomized controlled tria… Pending

2025-521039-35-00 Phase III 1 country DEXMEDETOMIDINE; MIDAZOLAM
morPHinE clearance and glomerular filtration in the Drepanocytic in crisis in REAnimation. Recruiting

2024-511985-34-00 Phase IV 1 country IOHEXOL; MORPHINE HYDROCHLORIDE
PHArmacoKinetics of methYLphenidate in adult patients with ADHD: comparison between patients with and without OBesity_PHACYLOB. Recruiting

2024-519461-22-00 Phase IV 1 country METHYLPHENIDATE HYDROCHLORIDE
Apneic oxygenation with high-flow nasal oxygenation after preoxygenation with noninvasive ventilation before intubation in hypoxemic patient… Recruiting

2024-514949-11-00 Phase III 1 country OXYGEN
CASPONEB - Phase II safety lead-in randomized blind placebo controlled clinical trial : efficacy and safety of caspofungin aerosols for the … Recruiting

2023-508861-34-00 Phase I/II 1 country
Effect of long-term carvedilol to prevent decompensation or death in patients with asymptomatic Child-Pugh A5 to B8 cirrhosis and clinically… Recruiting

2024-511663-28-00 Phase IV 1 country CARVEDILOL
Traitement des Idées Suicidaires aux urgences par adjonction de Protoxyde d’Azote (PROTORISC pilote) Recruiting

2023-506329-12-00 Phase II 1 country NITROGEN, OXYGEN; NITROUS OXIDE, OXYGEN
Randomized, controlled, multicenter Phase I/II study comparing the safety and immunogenicity of a booster dose of an intranasal COVID-19 vac… Recruiting

2024-510589-17-00 Phase I (FiH) 1 country BRETOVAMERAN; LVT-001
Chimiothérapie à base de bevacizumab adaptée à la pharmacocinétique du bevacizumab en 1ère ligne de traitement du cancer colorectal métastat… Recruiting

2023-507873-16-00 Phase III/IV 1 country BEVACIZUMAB; SODIUM CHLORIDE
NEFARTHRO - Effets précoces et tardifs du néfopam dans l'analgésie multimodale après arthroplastie totale de hanche Recruiting

2023-504079-26-01 Phase III 1 country NEFOPAM; SODIUM CHLORIDE
Chronic anticoagulation in end-stage renal disease patients: pharmacocinetics and pharmacodynamic of a reduced dose regimen of rivaroxaban (… Recruiting

2023-505733-28-00 Phase II 1 country RIVAROXABAN
EvER-ILD 3 : Evaluation of Efficacy and safety of Rituximab and mycophenolate mofetil combination in patients with Interstitial Lung Disease… Recruiting

2023-510507-21-00 Phase II/III 1 country
Weaning protocol for high-flow nasal oxygen therapy in the ICU - Multicenter randomized controlled trial. HiFloWEAN Recruiting

2023-504366-36-00 Phase III 1 country OXYGEN
FIRE Stones : Impact of Furosemide on the residual fragment rate after flexible ureteroscopy for destruction of kidney stones with laser : a… Recruiting

2022-502890-40-00 Phase III 1 country
INduction in Sensitized kidney Transplant recipients without pre-Existing donor-specific AntiboDies: a randomized multicentre trial between … Recruiting

2022-502007-30-00 Phase III 1 country BASILIXIMAB; RABBIT ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN
THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN … Recruiting

2022-501494-39-00 Phase III 1 country
EvER-ILD 2: Evaluation of Efficacy and safety of Rituximab in patients with progressive Interstitial Lung Disease (ILD) with inflammatory co… Recruiting

2022-501335-16-00 Phase II/III 1 country

Showing 1–24 of 29 trials

← All sponsors A–Z